Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.68USD
3:59pm EST
Change (% chg)

$-0.01 (-1.17%)
Prev Close
$0.69
Open
$0.75
Day's High
$0.75
Day's Low
$0.68
Volume
45,739
Avg. Vol
56,637
52-wk High
$2.91
52-wk Low
$0.66

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Aug '17 1.19 -0.083
May '17 2.00 -0.059
Feb '17 1.24 -0.066
FY 2016 Nov '16 0.57 -0.134
Aug '16 0.55 -0.074
May '16 0.56 -0.081
Feb '16 0.57 -0.087
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Feb-18 2 1.28 1.33 1.23 19.29
Quarter Ending May-18 2 1.34 1.39 1.29 19.77
Year Ending Nov-18 4 9.29 15.80 6.17 44.97
Year Ending Nov-19 3 19.79 26.30 11.52 75.19
Earnings (per share)
Quarter Ending Feb-18 2 -0.05 -0.05 -0.05 0.38
Quarter Ending May-18 2 -0.05 -0.05 -0.06 0.39
Year Ending Nov-18 4 -0.18 -0.01 -0.28 0.67
Year Ending Nov-19 3 -0.08 0.05 -0.20 1.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.45 35.76
P/E High - Last 5 Yrs. -- 41.44 46.66
P/E Low - Last 5 Yrs. -- 23.40 24.18
Beta 1.15 0.81 0.81
Price to Sales (TTM) 4.81 6.28 8.59
Price to Book (MRQ) -- 4.38 5.23
Price to Tangible Book (MRQ) -- 4.85 6.37
Price to Cash Flow (TTM) -- 23.23 26.13
% Owned Institutions 0.49 1.25 2.31

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.50
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.25
Payout Ratio(TTM) -- 45.34 44.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 114.39 8.71 9.62
Sales (TTM) vs TTM 1 Yr. Ago 98.01 6.38 7.31
Sales - 5 Yr. Growth Rate 34.96 9.89 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.90 14.84 18.60
EPS (TTM) vs TTM 1 Yr. Ago 7.31 -- --
EPS - 5 Yr. Growth Rate -- 10.37 11.47
Capital Spending - 5 Yr. Growth Rate 14.48 14.63 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.48 2.39 2.43
Current Ratio (MRQ) 0.52 3.34 3.39
LT Debt to Equity (MRQ) -- 9.12 11.95
Total Debt to Equity (MRQ) -- 12.31 15.32
Interest Coverage (TTM) -47.40 44.69 38.67

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 52.12 55.21 54.89
Gross Margin - 5 Yr. Avg. -- 52.54 52.59
EBITD Margin (TTM) -187.01 -- --
EBITD - 5 Yr. Avg -211.00 18.58 10.03
Operating Margin (TTM) -195.92 11.50 2.96
Operating Margin - 5 Yr. Avg. -224.23 14.39 5.27
Pre-Tax Margin (TTM) -205.37 11.87 3.78
Pre-Tax Margin - 5 Yr. Avg. -233.31 14.67 5.53
Net Profit Margin (TTM) -205.37 8.25 0.26
Net Profit Margin - 5 Yr. Avg. -233.31 10.98 1.79
Effective Tax Rate (TTM) -- 22.40 22.06
Effective Tax Rate - 5 Yr. Avg. -- 23.58 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 924,682,765 824,372,705
Net Income/Employee (TTM) -- 108,239,788 96,444,553
Receivable Turnover (TTM) 8.31 5.30 5.41
Inventory Turnover (TTM) -- 2.60 3.49
Asset Turnover (TTM) 0.83 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -170.63 11.15 10.73
Return on Assets - 5 Yr. Avg. -144.35 12.66 12.02
Return on Investment (TTM) -578.34 14.04 13.59
Return on Investment - 5 Yr. Avg. -462.28 16.57 15.73
Return on Equity (TTM) -2,136.30 15.50 15.20
Return on Equity - 5 Yr. Avg. -- 17.65 16.95
  1 Year 3 Year 5 Year
Sales % -45.11 13.73 34.96
EPS (TTM) % -21.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellipharmaceutics International Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.